🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the diagnostic efficacy and prognostic value of...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2026-02-01
Trial ID
NCT07370805
Treatments Being Tested
As a novel radiotracer targeting fibroblast activation protein (FAP), 68Ga-...
Status
Unknown
Location
The First Affiliated Hospital of Fujian Medical University
Start Date
2024-04-01
Trial ID
NCT06455761
Treatments Being Tested
The clinical feasibility of 18F-FAPI-RGD PET/CT will be evaluated in 100 pa...
Status
Unknown
Location
Departments of Nuclear Medicine, Sichuan Provincial People's Hospital
Start Date
2023-04-10
Trial ID
NCT06094530
To explore the potential utility of 18F-FAPI-04 PET/CT for pathologic respo...
Status
Completed
Location
First Affiliated Hospital, Medical College of Zhejiang University
Start Date
2021-08-04
Trial ID
NCT06277206
Treatments Being Tested
Pancreatic adenocarcinoma commonly referred to as pancreatic cancer is a ca...
Status
Recruiting
Location
Tata Memorial Hospital, Mumbai, India
Start Date
2025-01-04
Trial ID
NCT07342231
Treatments Being Tested
Fibroblast-activation protein (FAP) is a type Ⅱ transmembrane serine protea...
Status
Recruiting
Location
Zhongnan Hospital of Wuhan University
Start Date
2021-02-23
Trial ID
NCT05034146
The goal of this clinical trial is to investigate whether new imaging techn...
Status
Recruiting
Location
University Hospital Zurich
Start Date
2025-10-20
Trial ID
NCT07112066
Treatments Being Tested
Evaluating fluoro-18-fibroblast activation protein inhibitor-04 positron em...
Status
Completed
Location
The Second Hospital of Lanzhou University
Start Date
2022-04-01
Trial ID
NCT06206642
Treatments Being Tested
Ischemic heart failure (IHF) is the final stage of coronary heart disease. ...
Status
Recruiting
Location
Beijing Chaoyang Hospital, Capital Medical University
Start Date
2026-04-10
Trial ID
NCT07657650
Non-alcoholic fatty liver disease (NAFLD), estimated to be 17% prevalent in...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-01
Trial ID
NCT06160271
Treatments Being Tested